Infinity Pharmaceuticals

Infinity Pharmaceuticals EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Infinity Pharmaceuticals (INFIQ) as of Nov 19, 2026 is 0.83. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 1.76 — a change of -52.59% (lower).

EV/EBITDA

0.83

YoY

-52.59%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Infinity Pharmaceuticals is 2022 0.83 . EV/EBITDA (Enterprise Value to EBITDA) of Infinity Pharmaceuticals was 2021 1.76 . It decreases by -52.59% lower compared to the previous year.

The Infinity Pharmaceuticals EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2015
1.77 USD
Jan 1, 2016
0.51 USD
Jan 1, 2017
1.42 USD
Jan 1, 2018
4.92 USD
Jan 1, 2019
0.88 USD
Jan 1, 2020
0.28 USD
Jan 1, 2021
1.76 USD
Jan 1, 2022
0.83 USD
The Infinity Pharmaceuticals EV/EBITDA history
YEAREV/EBITDAYoY
0.83-52.59%
1.76+537.31%
0.28-68.60%
0.88-82.15%
4.92+247.38%
1.42+179.80%
0.51-71.41%
1.77-95.79%
42.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

EV/EBITDA (Enterprise Value to EBITDA) of Infinity Pharmaceuticals is 0.83 in 2022.

EV/EBITDA (Enterprise Value to EBITDA) of Infinity Pharmaceuticals changed from 1.76 to 0.83, representing a -52.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals